Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of raltegravir effect on HIV-1 latency and reservoir in patients on HAART
2008-005292-10Phase 2Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of raltegravir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoints: Size of latent HIV-1 reservoir and Frequency of resting CD4+ T cells infected with replication-competent virus. Started Sep 2008; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2008-005292-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005292-10.